MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Abbott Laboratories

Fechado

SetorSaúde

132.08 0.37

Visão Geral

Variação de preço das ações

24h

Atual

Mín

129.76

Máximo

132.11

Indicadores-chave

By Trading Economics

Rendimento

7.6B

9.2B

Vendas

339M

11B

P/E

Médio do Setor

17.363

63.778

EPS

1.34

Rendimento de Dividendos

1.78

Margem de lucro

84.099

Funcionários

114,000

EBITDA

82M

3B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+6.47% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.78%

2.39%

Próximos Ganhos

16 de abr. de 2025

Próxima data de dividendos

15 de mai. de 2025

Próxima data de ex-dividendo

15 de abr. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

7.8B

230B

Abertura anterior

131.71

Fecho anterior

132.08

Sentimento de Notícias

By Acuity

27%

73%

81 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Abbott Laboratories Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de jan. de 2025, 19:03 UTC

Ganhos

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 de jan. de 2025, 18:20 UTC

Ganhos

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 de jan. de 2025, 12:45 UTC

Ganhos

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

1 de nov. de 2024, 14:15 UTC

Grandes Movimentos do Mercado

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 de nov. de 2024, 10:10 UTC

Grandes Movimentos do Mercado

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 de out. de 2024, 23:57 UTC

Ações em Alta

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 de out. de 2024, 23:14 UTC

Grandes Movimentos do Mercado

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 de out. de 2024, 12:03 UTC

Ganhos

Abbott Laboratories 3Q Sales Top Expectations

1 de fev. de 2025, 18:14 UTC

Principais Notícias

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 de jan. de 2025, 16:40 UTC

Principais Notícias
Ganhos

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 de jan. de 2025, 15:20 UTC

Ganhos

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 de jan. de 2025, 15:08 UTC

Ganhos

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 de jan. de 2025, 13:51 UTC

Ganhos

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 de jan. de 2025, 13:39 UTC

Principais Notícias
Ganhos

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 de jan. de 2025, 12:02 UTC

Ganhos

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 de jan. de 2025, 12:01 UTC

Ganhos

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 de jan. de 2025, 12:01 UTC

Ganhos

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs 4Q Net $9.23B >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs 4Q Sales $10.97B >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs 4Q Organic Sales Growth Up 8.8% >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs 4Q EPS $5.27 >ABT

22 de jan. de 2025, 12:00 UTC

Ganhos

Abbott Labs 4Q Adj EPS $1.34 >ABT

22 de jan. de 2025, 09:54 UTC

Ações em Alta

Stocks to Watch Wednesday: Netflix, Oracle, Trump Media, Softbank -- WSJ

1 de nov. de 2024, 17:33 UTC

Conversa de Mercado

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 de out. de 2024, 14:21 UTC

Principais Notícias
Ganhos

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 de out. de 2024, 12:25 UTC

Ganhos

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 de out. de 2024, 12:02 UTC

Principais Notícias
Ganhos

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 de out. de 2024, 11:59 UTC

Ganhos

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 de out. de 2024, 11:37 UTC

Ganhos

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

Comparação entre Pares

Variação de preço

Abbott Laboratories Previsão

Preço-alvo

By TipRanks

6.47% parte superior

Previsão para 12 meses

Média 140.21 USD  6.47%

Máximo 158 USD

Mínimo 117 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para Abbott Laboratories - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

16 ratings

14

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

126.3 / 133.46Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

81 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.